http://www.serestherapeutics.com
Seres Therapeutics, Inc. Company Intro
Our mission is to transform the lives of patients worldwide with revolutionary microbiome therapeutics. Discover our progress.
Industry
Healthcare
Seres Therapeutics, Inc. Headquaters
200 Sidney Street
Cambridge,02139
United States
Seres Therapeutics, Inc. Share price
14 Sep 2022 09:42 GMT
$6.69
-0.24 (-3.46 %)
Seres Therapeutics, Inc. Market cap
$619.049 M
WMC RANKING
2022
Seres Therapeutics, Inc. # 134
BiotechnologyLatest Seres Therapeutics, Inc. News
05 Dec 2022
Swiss National Bank Sells 11500 Shares of Seres ...
grew its holdings in shares of Seres Therapeutics by 2.5% during the first quarter. Charles Schwab Investment Management Inc. now owns 482,178 shares of the...
05 Dec 2022
Swiss National Bank Has $519000 Stock Holdings in Seres ...
Y Intercept Hong Kong Ltd bought a new position in Seres Therapeutics in the second quarter valued at about $49,000. Blueshift Asset Management LLC acquired a...
05 Dec 2022
LifeMine Therapeutics Appoints Elliot Ehrich, M.D., as Chief ...
LifeMine Therapeutics Inc., a biopharmaceutical company refashioning drug ... tumor immunotherapy at Seres Therapeutics and as director of pharmacology and...
WMC Market Score
WMC Market to Revenue Score
Seres Therapeutics, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Seres Therapeutics, Inc. | USD | $30,744 | $134,508 | $-104,711 | $6,190M | 134 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $754,300B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $713,610B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $150,520B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Seres Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors
Seres Therapeutics, Inc. Post vs Top 4 Industry Competitors
Seres Therapeutics, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Seres Therapeutics, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Seres Therapeutics, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Seres Therapeutics, Inc. | 0.33 | 0.96 | 0.04 | 0 | 0 | 0 | 0.45 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 22 | 0 | 0 | 28.52 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 33 | 0 | 0 | 34.78 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 22 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 47.37 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
